units

PGC6010

Faculty of Pharmacy and Pharmaceutical Sciences

Postgraduate - Unit

This unit entry is for students who completed this unit in 2013 only. For students planning to study the unit, please refer to the unit indexes in the the current edition of the Handbook. If you have any queries contact the managing faculty for your course or area of study.

print version

6 points, SCA Band 2, 0.125 EFTSL

To find units available for enrolment in the current year, you must make sure you use the indexes and browse unit tool in the current edition of the Handbook.

LevelPostgraduate
FacultyFaculty of Pharmacy and Pharmaceutical Sciences
OfferedParkville First semester 2013 (Online)
Parkville Second semester 2013 (Online)
Coordinator(s)Ms Sharmila Khumra

Notes

For postgraduate coursework pharmacy discontinuation dates, please see http://www.pharm.monash.edu.au/students/pg-coursework/unit-discontinuation-dates.html

Quota applies

This unit is quota restricted. Selection is on a first-in, first enrolled basis. For more information please contact the faculty at http://www.pharm.monash.edu.au/courses/pg-coursework/contact.html

Synopsis

This unit will provide a broad overview or introduction to the treatment and management of infectious diseases. The focus will be on common infections seen in community and hospital settings, principles of microbiology and infectious diseases, antimicrobial use, and antimicrobial stewardship. The broad unit objectives are for students to develop and apply infectious diseases and antimicrobial use knowledge and skills in the care of patients, especially those with infections. These may be patients in the community or hospital settings. The knowledge and skills developed will be at a general level rather than at the level required for a specialist infectious diseases pharmacist.

Outcomes

On completion of the unit students will be able to:

  • Prepare and analyse treatment plans that optimise the use of anti-infectives.
  • Recommend approaches to manage patients requiring anti-infective therapies.
  • Demonstrate critical thinking, communication skills relevant to peers and patients and problem-solving, with a focus on infectious diseases related and anti-infectives related topics.

Assessment

Assignment 1: 30%
Assignment 2: 30%
Contribution to on-line discussions: 40%
Submission of a learning portfolio: pass/fail. A pass in this assessment task is required for an overall pass in this unit. (hurdle)

Chief examiner(s)

Contact hours

The student workload will be approximately 10-12 hours per week off campus

Prerequisites

There are no prerequisites however it is preferable for students to have completed PGC5001 Evidence based practice prior to enrolling into this unit.

Prohibitions

This unit cannot be taken with PGC6003 Patient data and pharmacotherapy II without prior approval from the relevant Course Director as there is significant overlap in content.